The DOI matches its Crossref record; 39 of the 44 references it cites were found in a registry or an index.
Association of Testosterone Levels With Anemia in Older Men: A Controlled Clinical Trial
Open accessAbstract
Importance: In one-third of older men with anemia, no recognized cause can be found. Objective: To determine if testosterone treatment of men 65 years or older with unequivocally low testosterone levels and unexplained anemia would increase their hemoglobin concentration. Design, Setting, and Participants: A double-blinded, placebo-controlled trial with treatment allocation by minimization using 788 men 65 years or older who have average testosterone levels of less than 275 ng/dL. Of 788 participants, 126 were anemic (hemoglobin ≤12.7 g/dL), 62 of whom had no known cause. The trial was conducted in 12 academic medical centers in the United States from June 2010 to June 2014. Interventions: Testosterone gel, the dose adjusted to maintain the testosterone levels normal for young men, or placebo gel for 12 months. Main Outcomes and Measures: The percent of men with unexplained anemia whose hemoglobin levels increased by 1.0 g/dL or more in response to testosterone compared with placebo. The statistical analysis was intent-to-treat by a logistic mixed effects model adjusted for balancing factors. Results: The men had a mean age of 74.8 years and body mass index (BMI) (calculated as weight in kilograms divided by height in meters squared) of 30.7; 84.9% were white. Testosterone treatment resulted in a greater percentage of men with unexplained anemia whose month 12 hemoglobin levels had increased by 1.0 g/dL or more over baseline (54%) than did placebo (15%) (adjusted OR, 31.5; 95% CI, 3.7-277.8; P = .002) and a greater percentage of men who at month 12 were no longer anemic (58.3%) compared with placebo (22.2%) (adjusted OR, 17.0; 95% CI, 2.8-104.0; P = .002). Testosterone treatment also resulted in a greater percentage of men with anemia of known cause whose month 12 hemoglobin levels had increased by 1.0 g/dL or more (52%) than did placebo (19%) (adjusted OR, 8.2; 95% CI, 2.1-31.9; P = .003). Testosterone treatment resulted in a hemoglobin concentration of more than 17.5 g/dL in 6 men who had not been anemic at baseline. Conclusions and Relevance: Among older men with low testosterone levels, testosterone treatment significantly increased the hemoglobin levels of those with unexplained anemia as well as those with anemia from known causes. These increases may be of clinical value, as suggested by the magnitude of the changes and the correction of anemia in most men, but the overall health benefits remain to be established. Measurement of testosterone levels might be considered in men 65 years or older who have unexplained anemia and symptoms of low testosterone levels. Trial Registration: clinicaltrials.gov Identifier: NCT00799617.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A meta-analysis of the literature suggests that men who have a history of unexplained anemia, 7 bone density loss, 8 diabetes, 9 exposure to chemotherapy, 10 direct or scatter radiation therapy to the testes, 11 HIV, 12 a history of chronic narcotic use, 13 infertility, 14 pituitary disorders, 15 and chronic corticosteroid use 16 are at risk for low testosterone.”
From Evaluation and Management of Testosterone Deficiency: AUA Guideline (2018) · cites this paper as [7]
Experimental — accuracy not yet measuredIn the citing paper
“10% of LSM induced weight loss with 2.9 nmol/L increase of total testosterone”
From Effects of liraglutide on obesity-associated functional hypogonadism in men (2019) · cites this paper as [21]
In the citing paper
“Five per cent of weight loss with LSM was associated with the 2 mmol/L increase of total testosterone and no increase of free testosterone (21)”
From Effects of liraglutide on obesity-associated functional hypogonadism in men (2019) · cites this paper as [21]
In the citing paper
“weight loss of more than 15% with increase by 5.7 mmol/L (21)”
From Effects of liraglutide on obesity-associated functional hypogonadism in men (2019) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Simple Sequentially Rejective Multiple Test Procedure
(1979) · Scandinavian Journal of Statistics · doi:10.2307/4615733 · Cited by 21,526
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2354 · Cited by 1,954
Self-citationFeldman, H. A., Longcope, C., Derby, C. A., Johannes, C. B., Araujo, A. B., Coviello, A. D., Bremner, W. J., & McKinlay, J. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8201 · Cited by 1,861
Guralnik, J. M., Eisenstaedt, R. S., Ferrucci, L., Klein, H. G., & Woodman, R. C. (2004) · Blood · doi:10.1182/blood-2004-05-1812 · Cited by 1,450
Redelmeier, D. A., Bayoumi, A. M., Goldstein, R. S., & Guyatt, G. H. (1997) · American journal of respiratory and critical care medicine · doi:10.1164/ajrccm.155.4.9105067 · Cited by 1,029
The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration?
Beutler, E., & Waalen, J. (2005) · Blood · doi:10.1182/blood-2005-07-3046 · Cited by 971
Effects of Testosterone Treatment in Older Men
Snyder, P. J., Bhasin, S., Cunningham, G. R., Matsumoto, A. M., Stephens-Shields, A. J., Cauley, J. A., Gill, T. M., Barrett-Connor, E., Swerdloff, R. S., Wang, C., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1506119 · Cited by 890
Self-citationWang, C., Cunningham, G., Dobs, A., Iranmanesh, A., Matsumoto, A. M., Snyder, P. J., Weber, T., Berman, N., Hull, L., & Swerdloff, R. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032006 · Cited by 656
Self-citationEffects of Testosterone Replacement in Hypogonadal Men1
Snyder, P. J., Peachey, H., Berlin, J. A., Hannoush, P., Haddad, G., Dlewati, A., Santanna, J., Loh, L., Lenrow, D. A., Holmes, J. H., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6731 · Cited by 610
Self-citation
Cited by
Sorted by citations
Items 201–239 of 239
Jayasena, C. N., & Quinton, R. (2021) · Clinical Endocrinology · doi:10.1111/cen.14432
Déficit en testostérone. Quels bénéfices et risques et pour quels patients ?
Faix, A., Cuzin, B., Desvaux, P., Huyghe, É., Lejeune, H., Almond, T., & Burte, C. (2021) · Sexologies · doi:10.1016/j.sexol.2021.06.003
(2021) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.9154
Benefits of Testosterone Treatment
Basaria, S. S., & Gagliano‐Jucá, T. (2022) · doi:10.1093/med/9780198870197.003.0489
Self-citationRisks of Testosterone Treatment
Dobs, A. S., & Yalamanchi, S. (2022) · doi:10.1093/med/9780198870197.003.0490
Anawalt, B. D. (2022) · doi:10.1093/med/9780198870197.003.0482
Dhindsa, S. (2022) · Wiley eBooks · doi:10.1002/9781119484288.ch85
Anemia in the Elderly. A Review
Куликов, И. А., & Demikhov, V. G. (2022) · Гематология Трансфузиология Восточная Европа · doi:10.34883/pi.2022.8.1.004
Hormone Replacement Therapy in Men
Pham, C. H., Wang, C., & Swerdloff, R. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.99449-2
Self-citationRana, M. K., & Rana, A. P. S. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.95540
Hypogonadism and Testosterone Therapy in Elderly Men
Yeap, B. B. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.66168-8
(2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.0248
Yoshino, Y., Wakabayashi, Y., & Kitazawa, T. (2022) · Current HIV Research · doi:10.2174/1570162x20666220623152941
Nieschlag, E., & Behre, H. M. (2021) · Springer Reference Medizin · doi:10.1007/978-3-662-61904-9_36-1
Benefits and Risks of Testosterone Replacement in the Older Man with Hypogonadism
Marcelli, M., & Mediwala, S. N. (2022) · Springer eBooks · doi:10.1007/978-3-030-99918-6_30
Latif, W. J. A., & Shaker, A. H. (2022) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2022.276699
Testosterone Therapy in Oncologic Patients
Solsrud, E., Louters, M. M., & Pearlman, A. M. (2023) · Current Sexual Health Reports · doi:10.1007/s11930-022-00351-w
Male Hypogonadism and Aging: An Update
Iglesias, P., Núñez, A., & Díez, J. J. (2023) · Springer eBooks · doi:10.1007/978-3-031-31501-5_9
Cardiovascular safety of testosterone replacement therapy
Čapka, D. (2023) · Urologie pro praxi · doi:10.36290/uro.2023.070
Testosteron – der Einfluss eines Sexualhormons auf den männlichen Körper
Jäger, T. (2024) · Springer eBooks · doi:10.1007/978-3-662-68405-4_1
Hypogonadism and testosterone therapy in elderly men
Yeap, B. B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00046-7
Männlicher Hypogonadismus und Alterung: ein Update
Iglesias, P., Núñez, A., & Díez, J. J. (2024) · Springer eBooks · doi:10.1007/978-3-031-65245-5_9
Shtein, K. A., & Babenko, A. Y. (2025) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-229-9-44-54
Reproductive and nonreproductive actions of testosterone
Gagliano‐Jucá, T., Jain, A., Jasuja, R., & Bhasin, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00198-9
Self-citationHormone replacement therapy, male
Wang, C., & Swerdloff, R. S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00263-6
Self-citationTestosterone Therapy in Men with Functional Hypogonadism
Mauvais‐Jarvis, F. (2025) · Springer eBooks · doi:10.1007/978-3-031-89650-7_15
History of Testosterone Therapy in Men with Testosterone Deficiency: 1939–2024
Traish, A. M. (2025) · Springer eBooks · doi:10.1007/978-3-031-89650-7_14
Hypogonadism in Men with Obesity and Type 2 Diabetes
Dhindsa, S., Ghanim, H., & Dandona, P. (2025) · Springer eBooks · doi:10.1007/978-3-031-89650-7_18
Testosterone Treatment of Late-Onset Hypogonadism: Benefits and Risks
Snyder, P. J. (2025) · Springer eBooks · doi:10.1007/978-3-031-96376-6_28
Self-citationTestosterone and Cardiovascular Disease
Goldman, A., & Bhasin, S. (2025) · Springer eBooks · doi:10.1007/978-3-031-96376-6_30
Self-citationLeydig Cell Function in Obesity and Diabetes
Grossmann, M. (2025) · Springer eBooks · doi:10.1007/978-3-031-96376-6_34
Testosterone Measurement, Use and Misuse
Handelsman, D. J. (2025) · Springer eBooks · doi:10.1007/978-3-031-96376-6_17
Aging hematopoietic system: Mechanisms, disorders, and therapeutic frontiers
Chen, L., Liu, Q., & Guan, D. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003809
Xu, Y., Cao, W., Shen, Y., Tang, J., Wang, Y., Ma, X., & Bao, Y. (2022) · Figshare · doi:10.6084/m9.figshare.19522665
Čeponis, J., Wang, C., Swerdloff, R., & Liu, P. Y. (2026) · Endocrinology · doi:10.1007/978-3-319-29456-8_11-2
Self-citationKey findings on the efficacy and safety of testosterone therapy from two large randomized trials
Braga, M., & Basaria, S. S. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag397
Self-citationQin, H., Zuo, D., Wang, Z., Li, L., Zuo, L., Lv, Y., Tu, S., Wang, J., Chen, Y., Li, X., et al. (2026) · Endocrine · doi:10.1007/s12020-026-04773-7
THE BIOCHEMISTRY OF TESTOSTERONE: A REVIEW AND SYNTHESIS OF CURRENT SCIENTIFIC EVIDENCE
Бондарева, А. В., Yemelianenko, E. R., & Stetsenko, S. O. (2026) · Актуальні проблеми сучасної медицини Вісник Української медичної стоматологічної академії · doi:10.31718/2077-1096.26.3.307
Update on testosterone deficiency and therapeutic options for testosterone replacement therapy
Thompson, T., Mubarak, M., Jones, T. H., Pearce, I., & Modgil, V. (2026) · Nature Reviews Urology · doi:10.1038/s41585-026-01190-3
Metadata
- Authors
- Roy, C. N., Snyder, P. J., Stephens-Shields, A. J., Artz, A. S., Bhasin, S., Cohen, H. J., Farrar, J. T., Gill, T. M., Zeldow, B., Cella, D., Barrett-Connor, E., Cauley, J. A., Crandall, J. P., Cunningham, G. R., Ensrud, K. E., Lewis, C. E., Matsumoto, A. M., Molitch, M. E., Pahor, M., Swerdloff, R. S., Cifelli, D., Hou, X., Resnick, S. M., Walston, J. D., Anton, S., Basaria, S., Diem, S. J., Wang, C., Schrier, S. L., & Ellenberg, S. S.
- Affiliations
- Johns Hopkins University (US)
- University of Pennsylvania (US)
- Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia
- University of Chicago (US)
- Brigham and Women's Hospital (US)
- Duke Medical Center (US)
- Yale University (US)
- Northwestern University (US)
- University of California San Diego (US)
- University of Pittsburgh (US)
- Albert Einstein College of Medicine (US)
- Baylor College of Medicine (US)
- University of Minnesota (US)
- University of Alabama at Birmingham (US)
- University of Washington (US)
- University of Florida (US)
- University of California, Los Angeles (US)
- National Institutes of Health (US)
- Stanford Medicine (US)
- Corresponding author
- Snyder, Peter J.
- ORCID
- Snyder, Peter J.
- Artz, Andrew S.
- Bhasin, Shalender
- Cohen, Harvey J.
- Farrar, John T.
- Gill, Thomas M.
- Zeldow, Bret
- Cella, David
- Barrett-Connor, Elizabeth
- Cauley, Jane A.
- Crandall, Jill P.
- Cunningham, Glenn R.
- Ensrud, Kristine E.
- Lewis, Cora E.
- Matsumoto, Alvin M.
- Molitch, Mark E.
- Swerdloff, Ronald S.
- Hou, Xiaoling
- Resnick, Susan M.
- Walston, Jeremy D.
- Anton, Stephen
- Basaria, Shehzad
- Diem, Susan J.
- Wang, Christina
- Ellenberg, Susan S.
- Venue
- JAMA Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2017-04-01
- Volume
- 177
- Issue
- 4
- Pages
- 480
- ISSN
- 2168-6106 (ISSN-L)
- PMC
- PMC5433757
- OpenAlex
- W2593639365
- Cited by
- 239
- References
- 44
- Citations by year
- 2026: 8 · 2025: 24 · 2024: 24 · 2023: 17 · 2022: 31 · 2021: 25 · 2020: 22 · 2019: 33 · 2018: 34 · 2017: 21
- FWCI
- 23.76
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- JAMA Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5p30ag031679-15, UL1TR001863)
- National Institute on Aging (U01AG030644, K07AG043587, P30-AG031679, U01AG034661, P30AG028740, P30AG021342)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK060455, P30DK020541)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Keywords
- testosterone replacement therapy, testosterone gel, anemia, older men, androgen deficiency, hemoglobin, anemia of chronic disease, cancer-related anemia
- MeSH terms
- Aged, Androgens, Anemia, Double-Blind Method, Drug Administration Routes, Hemoglobins, Humans, Male, Testosterone, Treatment Outcome, Drug Monitoring, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
